Newsletter - July 27, 2017
FDA Looks Forward to Consumer Complaints to Rein In Supplements
FDA and FTC want consumers to help them find sellers of dietary supplements who make dubious claims or sub-standard products. Seems simple enough, but it is not. The agencies need stronger laws and additional resources to enforce the laws regarding supplements. Consumer complaints are not the answer. Read More
Does Empowering Patients Mean “Better” Regulation of Drugs by FDA?
This week FDA announced several initiatives aimed at greater patient engagement in regulatory processes that could greatly affect future approval decisions and other regulatory actions by the Agency. Involving patients in regulatory processes humanizes the regulatory process by educating consumers about how the FDA works. Read More
FDA Looks Forward to Consumer Complaints to Rein In Supplements
FDA and FTC want consumers to help them find sellers of dietary supplements who make dubious claims or sub-standard products. Seems simple enough, but it is not. The agencies need stronger laws and additional resources to enforce the laws regarding supplements. Consumer complaints are not the answer. Read More
Does Empowering Patients Mean “Better” Regulation of Drugs by FDA?
This week FDA announced several initiatives aimed at greater patient engagement in regulatory processes that could greatly affect future approval decisions and other regulatory actions by the Agency. Involving patients in regulatory processes humanizes the regulatory process by educating consumers about how the FDA works. Read More
